Breast Cancer Research
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
CommentaryCortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cellsAgnes GSH van Rossum1 , Johan Gibcus2 , Jacqueline van der Wal2 and Ed Schuuring2  1
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands 2
Department of Pathology, University Medical Center Groningen, The Netherlands author email corresponding author email
Breast Cancer Research 2005,
7:235-237doi:10.1186/bcr1316
|
| Published: |
25 August 2005 |
Abstract
The chromosome 11q13 region is frequently amplified in human carcinomas and results in an increased expression of various genes including cortactin, and is also associated with an increased invasive potential. Cortactin acts as an important regulator of the actin cytoskeleton. It is therefore very tempting to speculate that cortactin is the crucial gene within the 11q13 amplicon that mediates the invasive potential of these carcinomas. Cortactin also participates in receptor-mediated endocytosis, and recent findings have shown that, during receptor internalization, cortactin overexpression inhibits the ubiquitylation-mediated degradation of the epidermal growth factor receptor, resulting in a sustained ligand-induced epidermal growth factor receptor activity. |